Aurinia Pharmaceuticals Inc (NASDAQ:AUPH)’s traded shares stood at 0.99 million during the latest session, with the company’s beta value hitting 1.19. At the last check today, the stock’s price was $8.09, to imply a decrease of -2.24% or -$0.18 in intraday trading. The AUPH share’s 52-week high remains $10.67, putting it -31.89% down since that peak but still an impressive 36.84% since price per share fell to its 52-week low of $5.11.
Analysts have given a consensus recommendation of Buy for Aurinia Pharmaceuticals Inc (AUPH), translating to a mean rating of 1.50. Of 3 analyst(s) looking at the stock, 0 analyst(s) give AUPH a Sell rating. 0 of those analysts rate the stock as Overweight while 1 advise Hold as 2 recommend it as a Buy.
Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) trade information
After registering a -2.24% downside in the latest session, Aurinia Pharmaceuticals Inc (AUPH) has traded red over the past five days. The 5-day price performance for the stock is -1.28%, and -0.19% over 30 days. With these gigs, the year-to-date price performance is -9.97%.
The extremes give us $6 and $13 for target low and target high price respectively. As such, AUPH has been trading -60.69% off suggested target high and 25.83% from its likely low.
AUPH Dividends
Aurinia Pharmaceuticals Inc has its next earnings report out in June. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
The next major institution holding the largest number of shares is BLACKROCK INC. with 9.27 million shares, or about 6.4692% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $52.94 million.
We also have iShares Trust-iShares Russell 2000 ETF and Fidelity Salem Street Trust-Fidelity Small Cap Index Fund as the top two Mutual Funds with the largest holdings of the Aurinia Pharmaceuticals Inc (AUPH) shares. Going by data provided on Mar 31, 2025 , iShares Trust-iShares Russell 2000 ETF holds roughly 3.52 shares. This is just over 2.60% of the total shares, with a market valuation of $28.52 million. Data from the same date shows that the other fund manager holds a little less at 1.33, or 0.99% of the shares, all valued at about 10.81 million.
